Table 7

Associations between the use of infliximab and patient, disease and treatment characteristics for patients with Crohn's disease (n = 1787)

Characteristics

% Reporting Infliximab

Odds ratio

95% CI


Sex

Male

5.5

Referent

Female

5.6

1.0

0.7 to 1.6

Age

16–24

11.6

Referent

25–40

7.7

0.6

0.3 to 1.3

41–55

4.8

0.4

0.2 to 0.8

>55

2.7

0.2

0.1 to 0.5

Disease activity

Inactive

1.8

Referent

Mild

2.3

1.3

0.5 to 3.3

Moderate

5.4

3.0

1.3 to 7.4

Severe

21.1

14.4

5.7 to 36.3

Prior hospitalization

No

1.7

Referent

Yes

6.3

3.9

1.6 to 9.6

Surgery within the past 2 years

No

4.6

Referent

Yes

11.4

2.7

1.7 to 4.2

IV Steroids in past 12 months

No

4.8

Referent

Yes

18.9

4.6

2.6 to 8.2

PO Steroids in past 12 months

No

2.5

Referent

Yes

11.2

5.0

3.2 to 7.8

PO 6 MP/Azathioprine in past 12 months

No

3.6

Referent

Yes

11.8

3.6

2.4 to 5.4


Hilsden et al. BMC Gastroenterology 2003 3:10   doi:10.1186/1471-230X-3-10

Open Data